Keep learning!
Nanobodies raised against the cytotoxic α-synuclein oligomer are oligomer-specific and promote its cellular uptake
This study raised two llama nanobodies against the cytotoxic α-synuclein oligomer linked to Parkinson's disease, and showed that they recognise the oligomer but not the monomer and help cells take up the oligomer through the receptor sortilin. Flow Induced Dispersion Analysis (FIDA) was used to measure binding in solution. Fluorescently labelled nanobodies were titrated with oligomer, and the increase in their hydrodynamic radius gave binding curves with a KD of about 31 nM (NB1) and 41 nM (NB2), while monomer caused no change, confirming oligomer specificity. FIDA also characterised DNA-scaffolded nanobody constructs. Affinities were compared with surface plasmon resonance and biolayer interferometry; agreement with SPR was close for NB2 but not for NB1. It is an example of using FIDA to measure nanobody binding and target selectivity for a large, heterogeneous oligomer in solution.